Access to page content (press "Enter") Direct access to search form (press "Enter")
European Parliament Logo, European Science-Media Hub home page

European Science-Media Hub

Bringing scientists, journalists and policymakers together: communicate better sound science to all 

Home
  • Home
  • Infodemic
    • Fact checkers' initiatives
    • Articles
    • Interviews with experts on disinformation
    • Reports
  • About ESMH
    • Team
    • Our mission
    • Our community
    • ESMH advisory board
  • Publications
    • Articles
    • Media review
    • Interviews
    • Videos
    • Interactive maps
    • Science media intelligence reports
  • Events
    • ESMH Summer School
    • Past events
    • ESMH meets partners
  • Subscribe

Can intellectual property and open science go together? Interview with Gustav Nilsonne

Open science and intellectual property are often framed as pulling in opposite directions: one built on free dissemination of knowledge, the other on protecting and rewarding innovation through exclusive rights. But as the pace of scientific publishing accelerates and generative AI reshapes how research...

on October 07, 2026 - Articles, Policy, Communication
  • Interview with Philipp Schmid on science denialism, misinformation & the importance of public confidence in the safety & effectiveness of the Covid-19 vaccine

    Articles, Disinformation
    Dr. Philipp Schmid is a scientific researcher at the Department of Psychology at the University of Erfurt (Germany). Philipp’s research aims at analysing the psychological reasons of science denialism. He is the lead author of the WHO guideline on how to respond to vocal vaccine denier in public and...
    on January 06, 2021
  • What drives public trust? Broadening the traditional scope of science communication with TRESCA

    Articles, Disinformation

    The COVID-19 pandemic has accelerated the digitalisation of our daily lives and, by now, we are all a bit more dependent on technology than we had been before. But how can we trust all the scientific information that we receive through the media? How can we have a common understanding of what is reliable...

    on December 30, 2020
  • The (digital) future of work in the post-Covid-19 era

    Articles, New Technologies, Policy

    The coronavirus pandemic has accelerated digitalization and the adoption of new technologies that are having a profound effect on the way we work. It has highlighted the urgent need to protect workers’ rights and to adopt measures that ensure inclusive growth and close the digital divide.

    on December 23, 2020
  • Vaccination policy in times of Covid-19

    Articles, Health, Policy

    As multiple COVID-19 vaccines are emerging, what can be done to tackle vaccination hesitancy and ensure rapid and equitable deployment?

    on December 16, 2020
  • ESMH Press Review – December 10, 2020

    Media review

    COVID-19 misinformation, climate crisis & internet of things. Check out the ESMH selection of 20 science and tech news published in the last weeks on the web.

    on December 10, 2020
  • COVID-19: ensuring a safe and effective vaccine

    Articles, Health

    Scientists around the world are working hard to come up with a COVID-19 vaccine to suppress the pandemic. How can the EU guarantee that rapidly approved vaccines are safe and effective? We asked senior representatives from the European Medicines Agency (EMA) and the European Centre for Disease Prevention...

    on December 08, 2020
  • Tocilizumab : a treatment alternative in COVID-19 pneumonia

    Articles, Health, Research

    Patients with severe COVID-19 pneumonia often need to be mechanically intubated and have an increased mortality risk. Tocilizumab, a drug used against the cytokine storm underlying this clinical condition, has shown positive effects in clinical trials.

    on December 02, 2020
  • The key role of antivirals in COVID-19 treatment (remdesivir)

    Articles, Health

    A few weeks after the SARS-CoV-2 was identified by Chinese researchers as the cause of ‘COVID-19’, an antiviral called remdesivir, originally used during the 2014 Ebola outbreak, came into play as the first available option to treat patients with coronavirus disease 2019 (COVID-19). Even if the approval...

    on November 25, 2020
  • ◄
  • 1
  • ...
  • 37
  • 38
  • 39
  • 40
  • 41
  • ...
  • 67
  • ►
Search tool

Useful links

Categories

  • Videos (65)
  • ESMH meets partners (6)
  • EU projects (58)
  • Events (7)
  • Past Events (26)
  • Interviews (303)
  • Media review (72)
  • Other (15)
  • Outcomes (5)
  • STOA studies (5)
  • Articles (278)
  • Agriculture (3)
  • Artificial Intelligence (34)
  • Communication (32)
  • Disinformation (32)
  • Energy (6)
  • Environment (43)
  • Food (10)
  • Health (87)
  • Industry (3)
  • Information Society (9)
  • New Technologies (28)
  • Policy (32)
  • Research (26)
  • Robotics (3)
  • Security (3)
  • Social Sciences (10)
  • Space (2)
  • Society (10)
  • Transport (4)
  • Uncategorized (0)
  • Disclaimer & Copyright
  • Terms & Conditions
  • Contact ESMH
  • EPRS blog
  • STOA website
  • STOA on X
  • STOA on Bluesky
  • STOA on Linkedin
  • STOA on Youtube

Copyright © European Union, 2018. All rights reserved.